- Home
- ZJYL vs ITOS Comparison
ZJYL vs ITOS Comparison
Compare ZJYL & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZJYL
- ITOS
- Stock Information
- Founded
- ZJYL 2006
- ITOS 2011
- Country
- ZJYL China
- ITOS United States
- Employees
- ZJYL N/A
- ITOS N/A
- Industry
- ZJYL Industrial Specialties
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZJYL Consumer Discretionary
- ITOS Health Care
- Exchange
- ZJYL Nasdaq
- ITOS Nasdaq
- Market Cap
- ZJYL 320.9M
- ITOS 342.6M
- IPO Year
- ZJYL 2023
- ITOS 2020
- Fundamental
- Price
- ZJYL $1.06
- ITOS $8.32
- Analyst Decision
- ZJYL
- ITOS Strong Buy
- Analyst Count
- ZJYL 0
- ITOS 3
- Target Price
- ZJYL N/A
- ITOS $33.67
- AVG Volume (30 Days)
- ZJYL 323.8K
- ITOS 543.4K
- Earning Date
- ZJYL 07-26-2024
- ITOS 11-12-2024
- Dividend Yield
- ZJYL N/A
- ITOS N/A
- EPS Growth
- ZJYL N/A
- ITOS N/A
- EPS
- ZJYL 0.02
- ITOS N/A
- Revenue
- ZJYL $20,125,185.00
- ITOS $35,000,000.00
- Revenue This Year
- ZJYL N/A
- ITOS $271.18
- Revenue Next Year
- ZJYL N/A
- ITOS N/A
- P/E Ratio
- ZJYL $56.81
- ITOS N/A
- Revenue Growth
- ZJYL 0.75
- ITOS N/A
- 52 Week Low
- ZJYL $0.56
- ITOS $7.54
- 52 Week High
- ZJYL $25.49
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- ZJYL 24.53
- ITOS 39.51
- Support Level
- ZJYL $0.96
- ITOS $7.54
- Resistance Level
- ZJYL $2.20
- ITOS $8.38
- Average True Range (ATR)
- ZJYL 0.21
- ITOS 0.53
- MACD
- ZJYL -0.05
- ITOS 0.01
- Stochastic Oscillator
- ZJYL 8.06
- ITOS 35.94
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is primarily engaged in the design, development, manufacturing, and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's products are sold to distributors in both China and in overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, nursing products, and conlo products.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.